In vivo, a 1.9-fold upregulation of PSMA in tumor-bearing mice (C4-2 xenograft) by 10 mg/kg once daily (QD) apalutamide for 7 days was observed [68,69]. This evidence concerns the gene FOLH1 and neoplasm.